Le Lézard
Classified in: Health
Subject: AWD

EVERSANA CONSULTING Named a Forbes 2024 Top Management Consulting Firm in the United States


CHICAGO, March 12, 2024 /PRNewswire/ -- EVERSANAŽ, a leading provider of commercialization services to the global life sciences industry, announced today that its professional advisory firm, EVERSANA CONSULTING, has been ranked in the annual list of Top Management Consulting Firms in the United States by Forbes Magazine for 2024.

"Recognition from Forbes is among the highest honors a company can hold," said Jim Lang, CEO, EVERSANA. "While we all celebrate this honor, this is a testament to the individual expertise our consultants bring to clients. Daily they are applying their skills to solve the most complex challenges facing life science brands today. I learn from this team every day and know our clients are in the best hands."

Forbes partnered with Statista, the world-leading statistics portal and industry ranking provider, to produce its ninth annual list of America's Best Management Consulting Firms, comprised of the best consultancies based on results of an online, two-step methodology including expert and client surveys.   The listing is compiled by surveying 10,000 partners and executives of management consultancies, and more than 1,200 senior executives who worked with such firms over the last six years. It is divided into 16 sectors?from aerospace and defense to financial institutions?and 16 functional areas?including strategy, sustainability, and digital transformation. In total, 199 different firms were ranked across the United States in the 2024 ranking. 2024 marks the first time EVERSANA CONSULTING has been named to the prestigious list.

The most recent accolade for EVERSANA CONSULTING comes just weeks after the specialty consulting arm of EVERSANA also earned honors from Vault as a Top Consulting firm in both North America and the Asia Pacific region

EVERSANA CONSULTING serves a broad range of large and small biopharma, med tech and digital therapeutics companies. The team combines business strategy, launch excellence and commercial execution to provide end-to-end advisory services to clients. To learn more, visit eversanaconsulting.com.

About EVERSANAŽ
EVERSANAŽ is a leading independent provider of global services to the life sciences industry. The company's integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 650 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit eversana.com or connect through LinkedIn and X.

Media Contact

Matt Braun
EVERSANA
[email protected]

SOURCE EVERSANA


These press releases may also interest you

at 10:30
Flourishing Foundations Recovery has launched a new outpatient detox center in San Antonio, TX, aiming to help individuals tackle drug and alcohol addiction without pausing their daily lives. The new substance abuse treatment center ensures easy...

at 08:30
Toitures Hogue's commitment to providing its employees with a structured, professional working environment that guarantees complete safety in the workplace, both on the job and on the job site, has just been awarded its renewed ISO 45001...

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...



News published on and distributed by: